Antiepileptics for seizure prophylaxis after traumatic brain injury.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 24249751)

Published in Am J Health Syst Pharm on December 01, 2013

Authors

Heather Torbic1, Allison A Forni, Kevin E Anger, Jeremy R Degrado, Bonnie C Greenwood

Author Affiliations

1: Department of PharmacyBrigham and Women's Hospital75 Francis StreetBoston, MA 02115htorbic@partners.org.

Associated clinical trials:

Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates? | NCT03054285

Articles cited by this

Use of antiepileptics for seizure prophylaxis after traumatic brain injury. Am J Health Syst Pharm (2013) 2.08

Antiepileptics for seizure prophylaxis after traumatic brain injury. Am J Health Syst Pharm (2013) 1.07

Articles by these authors

Use of antiepileptics for seizure prophylaxis after traumatic brain injury. Am J Health Syst Pharm (2013) 2.08

Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care (2009) 1.47

Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm (2007) 1.07

Role of dexmedetomidine in adults in the intensive care unit: an update. Am J Health Syst Pharm (2013) 1.03

Evaluation of compliance with a paper-based, multiplication-factor, intravenous insulin protocol. Ann Pharmacother (2009) 0.86

Improving glycemic control in medical inpatients: a pilot study. J Hosp Med (2008) 0.83

Etanercept for the Treatment of Transplantation-Related Lung Injury After Hematopoietic Stem Cell Transplantation. Am J Ther (2015) 0.81

Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care (2013) 0.81

Evaluation of a local ICU sedation guideline on goal-directed administration of sedatives and analgesics. J Pain Res (2011) 0.79

Pharmacodynamic target attainment with high-dose extended-interval tobramycin therapy in patients with cystic fibrosis. J Chemother (2013) 0.77

Evaluation of recombinant activated protein C for severe sepsis at a tertiary academic medical center. Ther Clin Risk Manag (2013) 0.77

Evaluation of the maximum beyond-use-date stability of regular human insulin extemporaneously prepared in 0.9% sodium chloride in a polyvinyl chloride bag. Diabetes Metab Syndr Obes (2013) 0.75

Safety of Propofol for Oxygenator Exchange in Extracorporeal Membrane Oxygenation. ASAIO J (2016) 0.75

Enhanced responsibilities for pharmacy interns at a teaching hospital. J Am Pharm Assoc (2003) (2015) 0.75

Evaluation of an institution-wide guideline for hyperglycemic emergencies at a tertiary academic medical center. Ann Pharmacother (2013) 0.75

Implementation of a Prolonged Infusion Guideline for Time-Dependent Antimicrobial Agents at a Tertiary Academic Medical Center. Am J Ther (2016) 0.75

Inpatient pharmacological sleep aid utilization is common at a tertiary medical center. J Hosp Med (2014) 0.75

Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia. Pharmacotherapy (2013) 0.75

Using the high-dose corticotropin test to diagnose relative adrenal insufficiency in vasopressor-dependent septic shock. Am J Health Syst Pharm (2006) 0.75